4th Nov 2008 12:41
Corrected website link: www.sinclairpharmair.com
Sinclair Pharma plc 2008 Annual Report and Accounts
31 October 2008, Godalming, UK: Sinclair Pharma plc ("Sinclair": SPH:L), the international specialty pharma company, today announces that it has published its annual report and accounts for the year ended 30 June 2008.
The annual report & accounts are now available on the Company's website at http://www.sinclairpharmair.com
Copies of the annual report and accounts of the Company including notice of the Annual General Meeting of the Company and the form of proxy for use at the Annual General Meeting, will be submitted to the UK Listing Authority next week, at which point they will be available for inspection at the UK Listing Authority's Document Viewing Facility located at:-
Financial Services Authority
25 The North ColonnadeCanary WharfLondon E14 5HSTel: 020 7066 1000EnquiriesCapital MS&L
Mary Clark, Anna Mitchell Tel +44 (0)20 7307 5340
Notes to Editors:
About Sinclair Pharma Plc www.sinclairpharma.com
Sinclair Pharma plc is an international specialty pharmaceutical company. It has a growing sales and marketing operation that is already present in France, Italy, UK, Spain and Portugal, and a complementary marketing partner network that spans more than 80 countries.
Sinclair has proven expertise in acquiring or developing commercially attractive and undervalued products, registering these products and bringing them to market within a short timeframe. The company focuses on niche therapeutic areas and its current portfolio includes products for a wide range of dermatological conditions and oral health.
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward-looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward-looking statements due to a variety of factors.
vendorRelated Shares:
Sinclair Pharma